{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:19:01Z","timestamp":1792801141882,"version":"4.5.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["Grant No.81470352"],"award-info":[{"award-number":["Grant No.81470352"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["Grant No.81572713"],"award-info":[{"award-number":["Grant No.81572713"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Chinese Medicine Scientific Research Fundation of Shanghai Municipal Commission of Health and Family Planning","award":["Grant No.2014JP003A"],"award-info":[{"award-number":["Grant No.2014JP003A"]}],"id":[{"id":"https:\/\/ror.org\/03at7w331","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Fudan's Undergraduate Research Opportunities Program","award":["Grant No. 15108"],"award-info":[{"award-number":["Grant No. 15108"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Exp Clin Cancer Res"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s13046-017-0601-6","type":"journal-article","created":{"date-parts":[[2017,9,26]],"date-time":"2017-09-26T07:46:09Z","timestamp":1506411969000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Resveratrol inhibits Extranodal NK\/T cell lymphoma through activation of DNA damage response pathway"],"prefix":"10.1186","volume":"36","author":[{"given":"Xianxian","family":"Sui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Canjing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengxuan","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuling","family":"Zhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bobin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songmei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianhua","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,9,26]]},"reference":[{"key":"601_CR1","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.1182\/blood-2012-05-431460","volume":"120","author":"YL Kwong","year":"2012","unstructured":"Kwong YL, Kim WS, Lim ST, Kim SJ, Tang T, Tse E, Leung AYH, Chim CS. SMILE for natural killer\/T-cell lymphoma: analysis of safety and efficacy from the Asia lymphoma study group. Blood. 2012;120:2973\u201380.","journal-title":"Blood"},{"key":"601_CR2","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1038\/sj.leu.2403955","volume":"19","author":"YL Kwong","year":"2005","unstructured":"Kwong YL. Natural killer-cell malignancies: diagnosis and treatment. Leukemia. 2005;19:2186\u201394.","journal-title":"Leukemia"},{"issue":"Suppl 2","key":"601_CR3","first-page":"s84","volume":"10","author":"P Kanavaros","year":"1996","unstructured":"Kanavaros P, Briere J, Emile JF, Gaulard P. Epstein-Barr virus in T and natural killer (NK) cell non-Hodgkin's lymphomas. Leukemia. 1996;10(Suppl 2):s84\u20137.","journal-title":"Leukemia"},{"key":"601_CR4","doi-asserted-by":"crossref","first-page":"3563","DOI":"10.1093\/nar\/gkv212","volume":"43","author":"S Ramasubramanyan","year":"2015","unstructured":"Ramasubramanyan S, Osborn K, Al-Mohammad R, Naranjo Perez-Fernandez IB, Zuo J, Balan N, Godfrey A, Patel H, Peters G, Rowe M, et al. Epstein-Barr virus transcription factor Zta acts through distal regulatory elements to directly control cellular gene expression. Nucleic Acids Res. 2015;43:3563\u201377.","journal-title":"Nucleic Acids Res"},{"key":"601_CR5","doi-asserted-by":"crossref","first-page":"6297","DOI":"10.1182\/blood-2011-01-332379","volume":"117","author":"CM Shirley","year":"2011","unstructured":"Shirley CM, Chen J, Shamay M, Li H, Zahnow CA, Hayward SD, Ambinder RF. Bortezomib induction of C\/EBPbeta mediates Epstein-Barr virus lytic activation in Burkitt lymphoma. Blood. 2011;117:6297\u2013303.","journal-title":"Blood"},{"key":"601_CR6","doi-asserted-by":"crossref","first-page":"3080","DOI":"10.1093\/emboj\/19.12.3080","volume":"19","author":"R Feederle","year":"2000","unstructured":"Feederle R, Kost M, Baumann M, Janz A, Drouet E, Hammerschmidt W, Delecluse HJ. The Epstein-Barr virus lytic program is controlled by the co-operative functions of two transactivators. EMBO J. 2000;19:3080\u20139.","journal-title":"EMBO J"},{"key":"601_CR7","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1002\/path.2823","volume":"223","author":"S Ng","year":"2011","unstructured":"Ng S, Selvarajan V, Huang G, Zhou J, Feldman AL, Law M, Kwong Y, Shimizu N, Kagami Y, Aozasa K, et al. Activated oncogenic pathways and therapeutic targets in extranodal nasal-type NK\/T cell lymphoma revealed by gene expression profiling. J Pathol. 2011;223:496\u2013510.","journal-title":"J Pathol"},{"key":"601_CR8","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1111\/cas.12526","volume":"105","author":"M Yamaguchi","year":"2014","unstructured":"Yamaguchi M, Takata K, Yoshino T, Ishizuka N, Oguchi M, Kobayashi Y, Isobe Y, Ishizawa K, Kubota N, Itoh K, et al. Prognostic biomarkers in patients with localized natural killer\/T-cell lymphoma treated with concurrent chemoradiotherapy. Cancer Sci. 2014;105:1435\u201341.","journal-title":"Cancer Sci"},{"key":"601_CR9","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1016\/S0959-8049(02)00241-1","volume":"38","author":"PJ Farrell","year":"2002","unstructured":"Farrell PJ. Tumour viruses--could they be an Achilles' heel of cancer? Eur J Cancer. 2002;38:1815\u20136.","journal-title":"Eur J Cancer"},{"key":"601_CR10","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1038\/labinvest.2015.69","volume":"95","author":"J Yang","year":"2015","unstructured":"Yang J, Deng W, Hau PM, Liu J, Lau VM, Cheung AL, Huen MS, Tsao SW. Epstein-Barr virus BZLF1 protein impairs accumulation of host DNA damage proteins at damage sites in response to DNA damage. Lab Investig. 2015;95:937\u201350.","journal-title":"Lab Investig"},{"key":"601_CR11","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1182\/blood-2006-01-024703","volume":"109","author":"SP Perrine","year":"2007","unstructured":"Perrine SP, Hermine O, Small T, Suarez F, O'Reilly R, Boulad F, Fingeroth J, Askin M, Levy A, Mentzer SJ, et al. A phase 1\/2 trial of arginine butyrate and ganciclovir in patients with Epstein-Barr virus-associated lymphoid malignancies. Blood. 2007;109:2571\u20138.","journal-title":"Blood"},{"key":"601_CR12","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1038\/nm.1864","volume":"14","author":"D Fu","year":"2008","unstructured":"Fu D, Tanhehco Y, Chen J, Foss CA, Fox JJ, Chong J, Hobbs RF, Fukayama M, Sgouros G, Kowalski J, et al. Bortezomib-induced enzyme-targeted radiation therapy in herpesvirus-associated tumors. Nat Med. 2008;14:1118\u201322.","journal-title":"Nat Med"},{"key":"601_CR13","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1200\/JCO.2005.03.2573","volume":"24","author":"YX Li","year":"2006","unstructured":"Li YX, Yao B, Jin J, Wang WH, Liu YP, Song YW, Wang SL, Liu XF, Zhou LQ, He XH, et al. Radiotherapy as primary treatment for stage IE and IIE nasal natural killer\/T-cell lymphoma. J Clin Oncol. 2006;24:181\u20139.","journal-title":"J Clin Oncol"},{"key":"601_CR14","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/1756-8722-6-44","volume":"6","author":"N Lin","year":"2013","unstructured":"Lin N, Song Y, Zheng W, Tu M, Xie Y, Wang X, Ping L, Ying Z, Zhang C, Deng L, et al. A prospective phase II study of L-asparaginase- CHOP plus radiation in newly diagnosed extranodal NK\/T-cell lymphoma, nasal type. J Hematol Oncol. 2013;6:44.","journal-title":"J Hematol Oncol"},{"key":"601_CR15","doi-asserted-by":"crossref","unstructured":"Yamaguchi M, Suzuki R, Kwong YL, Kim WS, Hasegawa Y, Izutsu K, Suzumiya J, Okamura T, Nakamura S, Kawa K, et al. Phase I study of dexamethasone, methotrexate, ifosfamide, l-asparaginase, and etoposide (SMILE) chemotherapy for advanced-stage, relapsed or refractory extranodal natural killer (NK)\/T-cell lymphoma and leukemia. Cancer Sci. 2008;95:1016\u201320.","DOI":"10.1111\/j.1349-7006.2008.00768.x"},{"key":"601_CR16","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1007\/s12185-010-0726-2","volume":"92","author":"R Suzuki","year":"2010","unstructured":"Suzuki R. Treatment of advanced extranodal NK\/T cell lymphoma, nasal-type and aggressive NK-cell leukemia. Int J Hematol. 2010;92:697\u2013701.","journal-title":"Int J Hematol"},{"key":"601_CR17","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.phrs.2016.07.011","volume":"111","author":"L Morbidelli","year":"2016","unstructured":"Morbidelli L. Polyphenol-based nutraceuticals for the control of angiogenesis: analysis of the critical issues for human use. Pharmacol Res. 2016;111:384\u201393.","journal-title":"Pharmacol Res"},{"key":"601_CR18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.arr.2015.01.002","volume":"21","author":"MG Novelle","year":"2015","unstructured":"Novelle MG, Wahl D, Di\u00e9guez C, Bernier M, de Cabo R. Resveratrol supplementation: where are we now and where should we go? Ageing Res Rev. 2015;21:1\u201315.","journal-title":"Ageing Res Rev"},{"key":"601_CR19","first-page":"117r","volume":"7","author":"H Cai","year":"2015","unstructured":"Cai H, Scott E, Kholghi A, Andreadi C, Rufini A, Karmokar A, Britton RG, Horner-Glister E, Greaves P, Jawad D, et al. Cancer chemoprevention: Evidence of a nonlinear dose response for the protective effects of resveratrol in humans and mice. Sci Transl Med. 2015;7:117r\u2013298r.","journal-title":"Sci Transl Med"},{"key":"601_CR20","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1002\/jcp.25443","volume":"232","author":"A Alayev","year":"2017","unstructured":"Alayev A, Salamon RS, Schwartz NS, Berman AY, Wiener SL, Holz MK. Combination of rapamycin and resveratrol for treatment of bladder cancer. J Cell Physiol. 2017;232:436\u201346.","journal-title":"J Cell Physiol"},{"key":"601_CR21","doi-asserted-by":"crossref","first-page":"e55183","DOI":"10.1371\/journal.pone.0055183","volume":"8","author":"TL Quoc","year":"2013","unstructured":"Quoc TL, Espinoza JL, Takami A, Nakao S. Resveratrol induces cell cycle arrest and apoptosis in malignant NK cells via JAK2\/STAT3 pathway inhibition. PLoS One. 2013;8:e55183.","journal-title":"PLoS One"},{"key":"601_CR22","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/nrd2060","volume":"5","author":"JA Baur","year":"2006","unstructured":"Baur JA, Sinclair DA. Therapeutic potential of resveratrol: the in vivo evidence. Nat Rev Drug Discov. 2006;5:493\u2013506.","journal-title":"Nat Rev Drug Discov"},{"key":"601_CR23","doi-asserted-by":"crossref","first-page":"e1012976","DOI":"10.1080\/23723556.2015.1012976","volume":"2","author":"G Manic","year":"2015","unstructured":"Manic G, Obrist F, Sistigu A, Vitale I. Trial watch: targeting ATM-CHK2 and ATR-CHK1 pathways for anticancer therapy. Mol Cell Oncol. 2015;2:e1012976.","journal-title":"Mol Cell Oncol"},{"key":"601_CR24","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.tim.2007.01.003","volume":"15","author":"CE Lilley","year":"2007","unstructured":"Lilley CE, Schwartz RA, Weitzman MD. Using or abusing: viruses and the cellular DNA damage response. Trends Microbiol. 2007;15:119\u201326.","journal-title":"Trends Microbiol"},{"key":"601_CR25","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/nature01368","volume":"421","author":"CJ Bakkenist","year":"2003","unstructured":"Bakkenist CJ, Kastan MB. DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation. Nature. 2003;421:499\u2013506.","journal-title":"Nature"},{"key":"601_CR26","doi-asserted-by":"crossref","first-page":"7773","DOI":"10.1038\/sj.onc.1210881","volume":"26","author":"J Bartek","year":"2007","unstructured":"Bartek J, Bartkova J, Lukas J. DNA damage signalling guards against activated oncogenes and tumour progression. Oncogene. 2007;26:7773\u20139.","journal-title":"Oncogene"},{"key":"601_CR27","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/nature03482","volume":"434","author":"J Bartkova","year":"2005","unstructured":"Bartkova J, Horejsi Z, Koed K, Kramer A, Tort F, Zieger K, Guldberg P, Sehested M, Nesland JM, Lukas C, et al. DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis. Nature. 2005;434:864\u201370.","journal-title":"Nature"},{"key":"601_CR28","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/nyas.12796","volume":"1348","author":"RG Britton","year":"2015","unstructured":"Britton RG, Kovoor C, Brown K. Direct molecular targets of resveratrol: identifying key interactions to unlock complex mechanisms. Ann N Y Acad Sci. 2015;1348:124\u201333.","journal-title":"Ann N Y Acad Sci"},{"key":"601_CR29","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1016\/j.tiv.2015.04.015","volume":"29","author":"B Demoulin","year":"2015","unstructured":"Demoulin B, Hermant M, Castrogiovanni C, Staudt C, Dumont P. Resveratrol induces DNA damage in colon cancer cells by poisoning topoisomerase II and activates the ATM kinase to trigger p53-dependent apoptosis. Toxicol in Vitro. 2015;29:1156\u201365.","journal-title":"Toxicol in Vitro"},{"key":"601_CR30","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.3109\/10428194.2014.983099","volume":"56","author":"S Ng","year":"2015","unstructured":"Ng S, Ohshima K, Selvarajan V, Huang G, Choo S, Miyoshi H, Shimizu N, Reghunathan R, Chua H, Yeoh AE, et al. Epstein-Barr virus-associated T\/natural killer-cell lymphoproliferative disorder in children and young adults has similar molecular signature to extranodal nasal natural killer\/T-cell lymphoma but shows distinctive stem cell-like phenotype. Leukemia Lymphoma. 2015;56:2408.","journal-title":"Leukemia Lymphoma"},{"key":"601_CR31","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1126\/science.275.5297.218","volume":"5297","author":"M Jang","year":"1997","unstructured":"Jang M, Cai L, Udeani GO, Slowing KV. F TC, Beecher CW: cancer Chemopreventive activity of resveratrol, a natural product derived from grapes. Science. 1997;5297:218\u201320.","journal-title":"Science"},{"key":"601_CR32","doi-asserted-by":"crossref","first-page":"4977","DOI":"10.3390\/ijms15034977","volume":"15","author":"R Frazzi","year":"2014","unstructured":"Frazzi R, Tigano M. The multiple mechanisms of cell death triggered by resveratrol in lymphoma and leukemia. Int J Mol Sci. 2014;15:4977\u201393.","journal-title":"Int J Mol Sci"},{"key":"601_CR33","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1182\/blood.V92.3.996","volume":"3","author":"MV Cl\u00e9ment","year":"1998","unstructured":"Cl\u00e9ment MV, Hirpara JL, Chawdhury SH, Pervaiz S. Chemopreventive agent resveratrol, a natural product derived from grapes, triggers CD95 signaling-dependent apoptosis in human tumor cells. Blood. 1998;3:996\u20131002.","journal-title":"Blood"},{"key":"601_CR34","doi-asserted-by":"crossref","first-page":"71","DOI":"10.4161\/cbt.3.1.683","volume":"3","author":"AR Jazirehi","year":"2004","unstructured":"Jazirehi AR, Bonavida B. Resveratrol modifies the expression of apoptotic regulatory proteins and sensitizes non-Hodgkin's lymphoma and multiple myeloma cell lines to paclitaxel-induced apoptosis. Mol Cancer Ther. 2004;3:71\u201384.","journal-title":"Mol Cancer Ther"},{"key":"601_CR35","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.3945\/jn.109.105064","volume":"139","author":"SJ Zunino","year":"2009","unstructured":"Zunino SJ, Storms DH. Resveratrol alters proliferative responses and apoptosis in human activated B lymphocytes in vitro. J Nutr. 2009;139:1603\u20138.","journal-title":"J Nutr"},{"key":"601_CR36","first-page":"4731","volume":"61","author":"J Dorrie","year":"2001","unstructured":"Dorrie J, Gerauer H, Wachter Y, Zunino SJ. Resveratrol induces extensive apoptosis by depolarizing mitochondrial membranes and activating caspase-9 in acute lymphoblastic leukemia cells. Cancer Res. 2001;61:4731\u20139.","journal-title":"Cancer Res"},{"key":"601_CR37","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2147\/CMAR.S4544","volume":"1","author":"AV Nguyen","year":"2009","unstructured":"Nguyen AV, Martinez M, Stamos MJ, Moyer MP, Planutis K, Hope C, Holcombe RF. Results of a phase I pilot clinical trial examining the effect of plant-derived resveratrol and grape powder on Wnt pathway target gene expression in colonic mucosa and colon cancer. Cancer Manag Res. 2009;1:25\u201337.","journal-title":"Cancer Manag Res"},{"issue":"Suppl 1","key":"601_CR38","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1002\/mnfr.200800177","volume":"53","author":"L Almeida","year":"2009","unstructured":"Almeida L, Vaz-da-Silva M, Falcao A, Soares E, Costa R, Loureiro AI, Fernandes-Lopes C, Rocha JF, Nunes T, Wright L, Soares-da-Silva P. Pharmacokinetic and safety profile of trans-resveratrol in a rising multiple-dose study in healthy volunteers. Mol Nutr Food Res. 2009;53(Suppl 1):S7\u2013S15.","journal-title":"Mol Nutr Food Res"},{"key":"601_CR39","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.exphem.2013.04.004","volume":"41","author":"J Tomic","year":"2013","unstructured":"Tomic J, McCaw L, Li Y, Hough MR, Ben-David Y, Moffat J, Spaner DE. Resveratrol has anti-leukemic activity associated with decreased O-GlcNAcylated proteins. Exp Hematol. 2013;41:675\u201386.","journal-title":"Exp Hematol"},{"key":"601_CR40","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1038\/nature01101","volume":"419","author":"VS Marsden","year":"2002","unstructured":"Marsden VS, O'Connor L, O'Reilly LA, Silke J, Metcalf D, Ekert PG, Huang DC, Cecconi F, Kuida K, Tomaselli KJ, et al. Apoptosis initiated by Bcl-2-regulated caspase activation independently of the cytochrome c\/Apaf-1\/caspase-9 apoptosome. Nature. 2002;419:634\u20137.","journal-title":"Nature"},{"key":"601_CR41","first-page":"5315","volume":"58","author":"I Tamm","year":"1998","unstructured":"Tamm I, Wang Y, Sausville E, Scudiero DA, Vigna N, Oltersdorf T, Reed JC. IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs. Cancer Res. 1998;58:5315\u201320.","journal-title":"Cancer Res"},{"key":"601_CR42","first-page":"902","volume":"26","author":"J Ge","year":"2013","unstructured":"Ge J, Liu Y, Li Q, Guo X, Gu L, Ma ZG, Zhu YP. Resveratrol induces apoptosis and autophagy in T-cell acute lymphoblastic leukemia cells by inhibiting Akt\/mTOR and activating p38-MAPK. Biomed Environ Sci. 2013;26:902\u201311.","journal-title":"Biomed Environ Sci"},{"key":"601_CR43","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1016\/j.leukres.2013.09.010","volume":"37","author":"Y Suzuki","year":"2013","unstructured":"Suzuki Y, Ito S, Sasaki R, Asahi M, Ishida Y. Resveratrol suppresses cell proliferation via inhibition of STAT3 phosphorylation and mcl-1 and cIAP-2 expression in HTLV-1-infected T cells. Leuk Res. 2013;37:1674\u20139.","journal-title":"Leuk Res"},{"key":"601_CR44","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1038\/ng.3358","volume":"47","author":"L Jiang","year":"2015","unstructured":"Jiang L, Gu Z, Yan Z, Zhao X, Xie Y, Zhang Z, Pan C, Hu Y, Cai C, Dong Y, et al. Exome sequencing identifies somatic mutations of DDX3X in natural killer\/T-cell lymphoma. Nat Genet. 2015;47:1061\u20136.","journal-title":"Nat Genet"},{"key":"601_CR45","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1182\/blood-2009-05-221275","volume":"115","author":"Y Huang","year":"2010","unstructured":"Huang Y, de Reynies A, de Leval L, Ghazi B, Martin-Garcia N, Travert M, Bosq J, Briere J, Petit B, Thomas E, et al. Gene expression profiling identifies emerging oncogenic pathways operating in extranodal NK\/T-cell lymphoma, nasal type. Blood. 2010;115:1226\u201337.","journal-title":"Blood"},{"key":"601_CR46","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/leu.2013.157","volume":"28","author":"A Bouchekioua","year":"2014","unstructured":"Bouchekioua A, Scourzic L, de Wever O, Zhang Y, Cervera P, Aline-Fardin A, Mercher T, Gaulard P, Nyga R, Jeziorowska D, et al. JAK3 deregulation by activating mutations confers invasive growth advantage in extranodal nasal-type natural killer cell lymphoma. Leukemia. 2014;28:338\u201348.","journal-title":"Leukemia"},{"key":"601_CR47","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1038\/leu.2009.91","volume":"23","author":"P Coppo","year":"2009","unstructured":"Coppo P, Gouilleux-Gruart V, Huang Y, Bouhlal H, Bouamar H, Bouchet S, Perrot C, Vieillard V, Dartigues P, Gaulard P, et al. STAT3 transcription factor is constitutively activated and is oncogenic in nasal-type NK\/T-cell lymphoma. Leukemia. 2009;23:1667\u201378.","journal-title":"Leukemia"},{"key":"601_CR48","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1093\/carcin\/bgi165","volume":"26","author":"A Tyagi","year":"2005","unstructured":"Tyagi A, Singh RP, Agarwal C, Siriwardana S, Sclafani RA, Agarwal R. Resveratrol causes Cdc2-tyr15 phosphorylation via ATM\/ATR-Chk1\/2-Cdc25C pathway as a central mechanism for S phase arrest in human ovarian carcinoma Ovcar-3 cells. Carcinogenesis. 2005;26:1978\u201387.","journal-title":"Carcinogenesis"},{"key":"601_CR49","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.bcp.2005.12.018","volume":"71","author":"T Shimizu","year":"2006","unstructured":"Shimizu T, Nakazato T, Xian MJ, Sagawa M, Ikeda Y, Kizaki M. Resveratrol induces apoptosis of human malignant B cells by activation of caspase-3 and p38 MAP kinase pathways. Biochem Pharmacol. 2006;71:742\u201350.","journal-title":"Biochem Pharmacol"},{"key":"601_CR50","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/cas.12141","volume":"104","author":"J Luis Espinoza","year":"2013","unstructured":"Luis Espinoza J, Takami A, Trung LQ, Nakao S. Ataxia-telangiectasia mutated kinase-mediated upregulation of NKG2D ligands on leukemia cells by resveratrol results in enhanced natural killer cell susceptibility. Cancer Sci. 2013;104:657\u201362.","journal-title":"Cancer Sci"},{"key":"601_CR51","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1158\/1078-0432.CCR-06-0743","volume":"12","author":"Y Pommier","year":"2006","unstructured":"Pommier Y, Weinstein JN, Aladjem MI, Kohn KW. Chk2 molecular interaction map and rationale for Chk2 inhibitors. Clin Cancer Res. 2006;12:2657\u201361.","journal-title":"Clin Cancer Res"},{"key":"601_CR52","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/ng845","volume":"30","author":"J Falck","year":"2002","unstructured":"Falck J, Petrini JH, Williams BR, Lukas J, Bartek J. The DNA damage-dependent intra-S phase checkpoint is regulated by parallel pathways. Nat Genet. 2002;30:290\u20134.","journal-title":"Nat Genet"},{"key":"601_CR53","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1146\/annurev.genet.36.060402.113540","volume":"36","author":"KA Nyberg","year":"2002","unstructured":"Nyberg KA, Michelson RJ, Putnam CW, Weinert TA. Toward maintaining the genome: DNA damage and replication checkpoints. Annu Rev Genet. 2002;36:617\u201356.","journal-title":"Annu Rev Genet"},{"key":"601_CR54","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1126\/science.1092734","volume":"303","author":"JE Chipuk","year":"2004","unstructured":"Chipuk JE, Kuwana T, Bouchier-Hayes L, Droin NM, Newmeyer DD, Schuler M, Green DR. Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis. Science. 2004;303:1010\u20134.","journal-title":"Science"},{"key":"601_CR55","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/leu.2010.6","volume":"24","author":"LJ Mah","year":"2010","unstructured":"Mah LJ, El-Osta A. Karagiannis TC: gammaH2AX: a sensitive molecular marker of DNA damage and repair. Leukemia. 2010;24:679\u201386.","journal-title":"Leukemia"},{"key":"601_CR56","doi-asserted-by":"crossref","first-page":"e1000605","DOI":"10.1371\/journal.ppat.1000605","volume":"4","author":"CA Moody","year":"2009","unstructured":"Moody CA. LA Laimins: human papillomaviruses activate the ATM DNA damage pathway for viral genome amplification upon differentiation. PLoS Pathog. 2009;4:e1000605.","journal-title":"PLoS Pathog"},{"key":"601_CR57","doi-asserted-by":"crossref","unstructured":"Di Domenico EG, Toma L, Bordignon V, Trento E, D'Agosto G, Cordiali-Fei P, Ensoli F. Activation of DNA damage response induced by the Kaposi's sarcoma-associated herpes virus. Int J Mol Sci. 2016;17","DOI":"10.3390\/ijms17060854"},{"key":"601_CR58","doi-asserted-by":"crossref","first-page":"e126088","DOI":"10.1371\/journal.pone.0126088","volume":"10","author":"R Wang'Ondu","year":"2015","unstructured":"Wang'Ondu R, Teal S, Park R, Heston L, Delecluse H, Miller G. DNA damage signaling is induced in the absence of Epstein\u2014Barr virus (EBV) lytic DNA replication and in response to expression of ZEBRA. PLoS One. 2015;10:e126088.","journal-title":"PLoS One"},{"key":"601_CR59","doi-asserted-by":"crossref","first-page":"8156","DOI":"10.1074\/jbc.M411405200","volume":"280","author":"A Kudoh","year":"2005","unstructured":"Kudoh A, Fujita M, Zhang L, Shirata N, Daikoku T, Sugaya Y, Isomura H, Nishiyama Y, Tsurumi T. Epstein-Barr virus lytic replication elicits ATM checkpoint signal transduction while providing an S-phase-like cellular environment. J Biol Chem. 2005;280:8156\u201363.","journal-title":"J Biol Chem"}],"container-title":["Journal of Experimental & Clinical Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-017-0601-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,18]],"date-time":"2020-10-18T03:53:18Z","timestamp":1602993198000},"score":1,"resource":{"primary":{"URL":"http:\/\/jeccr.biomedcentral.com\/articles\/10.1186\/s13046-017-0601-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,26]]},"references-count":59,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["601"],"URL":"https:\/\/doi.org\/10.1186\/s13046-017-0601-6","relation":{},"ISSN":["1756-9966"],"issn-type":[{"value":"1756-9966","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,26]]},"article-number":"133"}}